World News Insights
1-3 Minute Gist
Search, personalize, or simply browse. Follow the world around you from gist and context to insights.
Who we are | Our Credo | Ways of using Lyrarc | FAQ | Send Feedback | First Letter From the Editor
Sign up. It's free and easy to use
Create an account
to personalize your feed of articles and topics.
All Topics Article
Analysis | The Trump administration is taking on drug prices — but not drug companies
Extremely high prices for some drugs in 2012-2016
07/25/2015
Grouped Articles
FDA Approves Cholesterol Drug From Regeneron, Sanofi
Wall Street Journal 07/25/2015
Washington Post 09/22/2015
Painted as EpiPen Villain, Mylan’s Chief Says She’s No Such Thing
The New York Times 08/26/2016
Mylan Reacts to EpiPen Backlash
WSJ 08/26/2016
Analysis | The Trump administration is taking on drug prices — but not drug companies
Washington Post 11/24/2017
Rapidly increasing prices of generic drugs 2013-2015
11/14/2014
Grouped Articles
Will Rising Prices for Some Generic Drugs Never End?
Wall Street Journal 11/14/2014
Painted as EpiPen Villain, Mylan’s Chief Says She’s No Such Thing
The New York Times 08/26/2016
Mylan Reacts to EpiPen Backlash
WSJ 08/26/2016
Analysis | The Trump administration is taking on drug prices — but not drug companies
Washington Post 11/24/2017
The renewed debate on drug pricing after the EpiPen price increases by Mylan Pharmaceutical
08/26/2016
Grouped Articles
Painted as EpiPen Villain, Mylan’s Chief Says She’s No Such Thing
The New York Times 08/26/2016
Mylan Reacts to EpiPen Backlash
WSJ 08/26/2016
EpiPen Maker Dispenses Outsize Pay
WSJ 09/13/2016
Lawmakers grill Mylan CEO over EpiPen price hikes
Washington Post 09/22/2016
Mylan’s EpiPen Pretax Profits 60% Higher Than Number Told to Congress
WSJ 09/26/2016
Analysis | The Trump administration is taking on drug prices — but not drug companies
Washington Post 11/24/2017
Price increases and cost of branded drugs and generic drugs- the pharmaceutical industry in 2011-2014
01/11/2010
Higer cost of specialty drugs for cancer, MS, other diseases, and the efforts by companies to squeeze profits from a shrinking branded portfolio push costs up for branded drugs. Prices of generics decline significantly. Express Scripts study shows 11% increase for branded drugs in 2011-2012 compared to 22% decrease for generics.
Grouped Articles
The Soaring Cost of a Simple Breath
New York Times 10/12/2013
AARP Study Says Price of Popular Drugs Rose 26%
New York Times 03/06/2012
Will Rising Prices for Some Generic Drugs Never End?
Wall Street Journal 11/14/2014
Washington Post 09/22/2015
Cost of Brand-Name Prescription Medicines Soaring
New York Times 11/28/2012
Beneath Budget Battle, a Health-Spending Juggernaut
Wall Street Journal 12/17/2012
U.S. biotech companies and pricing of new drugs in 2015
09/29/2015
Grouped Articles
Wall Street Journal 09/29/2015
Analysis | The Trump administration is taking on drug prices — but not drug companies
Washington Post 11/24/2017
By Adding Patents, Drugmaker Keeps Cheaper Humira Copies Out of U.S.
WSJ 10/16/2018
How Pfizer set the price of new breast cancer drug Ibrance at $9850 a month in 2015
12/09/2015
Rockoff describes the little known ways pharmaceutical companies come up with prices of expensive drugs, using Ibrance as an example.
Grouped Articles
How Pfizer Set the Cost of Its New Drug at $9,850 a Month
Wall Street Journal 12/09/2015
Painted as EpiPen Villain, Mylan’s Chief Says She’s No Such Thing
The New York Times 08/26/2016
Mylan Reacts to EpiPen Backlash
WSJ 08/26/2016
Analysis | The Trump administration is taking on drug prices — but not drug companies
Washington Post 11/24/2017
Turing Pharmaceuticals and the issue of exorbitant U.S. drug pricing in 2015
09/22/2015
Grouped Articles
Washington Post 09/22/2015
‘Pharma Bro’ Martin Shkreli arrested for securities fraud - The Washington Post
Washington Post 12/17/2015
Painted as EpiPen Villain, Mylan’s Chief Says She’s No Such Thing
The New York Times 08/26/2016
Mylan Reacts to EpiPen Backlash
WSJ 08/26/2016
Analysis | The Trump administration is taking on drug prices — but not drug companies
Washington Post 11/24/2017
Innovation and the pricing of drugs in the U.S. by the pharmaceutical companies.
06/09/2007
Will drug innovation be affected adversely by price reductions in the USA? No say experts as it is a globalized industry and innovation takes place in labs around the world. And the pricing reforms, as in Britian and Germany, can actually encourage R&D for effective drugs with good cost relationships; when comparitive effectiveness of drugs and cost benefit analyses is used in pricing reforms. Pricing of pharmaceutical products and healthcare services is the major unsolved problem in the U.S.
Grouped Articles
The Soaring Cost of a Simple Breath
New York Times 10/12/2013
New Medicines Emerge, but Few Blockbusters
Wall Street Journal 12/16/2013
New York Times 12/21/2013
FDA Approves Cholesterol Drug From Regeneron, Sanofi
Wall Street Journal 07/25/2015
Washington Post 09/22/2015
Settlement May Cut Drug Prices
Wall Street Journal 06/09/2007
We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.
Support Lyrarc from as small as $1
Terms and Conditions | Copyright Policy | Privacy Policy | Contact Us